乌司他丁对急性胰腺炎患者氧自由基清除能力及炎性应激的改善作用
Improvement Effect of Ulinastatin for the Oxygen Free Radical Scavenging Activity and Inflammatory Stress of Patients with Acute Pancreatitis
-
摘要: 目的 观察乌司他丁对急性胰腺炎患者氧自由基清除能力及炎性应激的改善作用.方法 选取2015年12月至2016年10月期间曲靖市第一人民医院收治的52例急性胰腺炎患者为观察对象, 将52例患者按照随机分配的原则分为对照组26例和观察组26例, 对照组进行常规急性胰腺炎治疗, 观察组则在对照组的基础上加用乌司他丁.将2组治疗前和治疗后不同时间的氧自由基清除能力及炎性应激指标进行比较.结果 治疗前对照组和观察组的氧自由基清除能力及炎性应激指标均差异无统计学意义 (P>0.05) , 而治疗后不同时间观察组的氧自由基清除能力及炎性应激指标均好于对照组同时间的检测结果, 差异有统计学意义 (P<0.05) .结论 乌司他丁对急性胰腺炎患者氧自由基清除能力及炎性应激的改善作用较好, 因此认为乌司他丁对此类患者的机体状态具有积极的保护作用.Abstract: Objective To study the improvement effect of ulinastatin for the oxygen free radical scavenging activity and inflammatory stress of patients with acute pancreatitis.Methods 52 patients with acute pancreatitis in our hospital from December 2015 to October 2016 were set as the observation object, and 52 patients were randomly divided into control group (26 cases) and observation group (26 cases) by the principle of random allocation. Patients in the control group were treated with routine treatment of acute pancreatitis, patients in the observation group were treated with ulinastatin on the basic treatment of control group.The oxygen free radical scavenging activity and inflammatory stress indexes of two groups before the treatment and at different time after the treatment were compared. Results The oxygen free radical scavenging activity and inflammatory stress indexes of control group and observation group before the treatment had no significant differences, all P >0.05, while the oxygen free radical scavenging activity and inflammatory stress indexes of observation group at different time after the treatment were all significantly better than the detection results of control group at the same time, all P<0.05, there were all significant differences. Conclusion The improvement effect of ulinastatin for the oxygen free radical scavenging activity and inflammatory stress of patients with acute pancreatitis is better, so the ulinastatin has active protection role for the body state of these patients.
-
[1]郝永胜.乌司他丁治疗重症胰腺炎的临床分析[J].中国卫生产业, 2013, 10 (21) :126. [2]代琳.国产乌司他丁治疗急性胰腺炎临床效果分析[J].中国现代药物应用, 2015, 9 (21) :161-162. [3]银德滨.乌司他丁联合丹红注射液治疗急性胰腺炎疗效分析[J].河北医药, 2013, 35 (14) :2221-2222. [4]孙兵, 施福田, 孟永前.奥曲肽联合乌司他丁对急性胰腺炎患者血清脂肪酶、CRP及临床疗效影响研究[J].中国生化药物杂志, 2015, 35 (12) :122-124. [5]顾书安, 王建国.乌司他丁联合奥曲肽对急性轻症胰腺炎患者四种血清IL水平的影响探讨[J].海峡药学, 2016, 28 (5) :159-160. [6]于水清.乌司他丁联合地芬诺酯治疗急性重症胰腺炎疗效观察[J].中国基层医药, 2013, 20 (19) :2942-2944. [7]田广.探讨急性胰腺炎患者的内科治疗效果观察[J].转化医学电子杂志, 2015, 2 (8) :37. [8]甄海洋, 朱宁.乌司他丁对急性胰腺炎患者疗效及炎性因子的影响观察[J].河北医药, 2016, 38 (12) :1768-1770. [9] [9]ABRAHAM P, RODRIQUES J, MOULICK N, et al.Efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis[J].J Assoc Physicians India, 2013, 61 (8) :535-538. [10] [10]DUR A, KOSE H, KOCYIGIT A, et al.The anti-inflammatory and antioxidant effects of thymoquinone on ceruleine induced acute pancreatitis in rats[J].Bratisl Lek Listy, 2016, 117 (10) :614-618. [11]刘洁, 袁小凌, 杨淑丽, 等.乌司他丁对大鼠急性坏死性胰腺炎的保护作用及相关机制的实验研究[J].中华胰腺病杂志, 2014, 14 (5) :334-337. [12]张更伟, 单爱军, 柳勋法, 等.大剂量山莨菪碱联合乌司他丁治疗重症胰腺炎[J].中华急诊医学杂志, 2014, 23 (2) :187-190. [13]吕建国.乌司他丁联合奥曲肽治疗重症急性胰腺炎的临床疗效分析[J].中国现代药物应用, 2014, 8 (7) :37-38. [14]尹静宜, 顾超.生长抑素联合乌司他丁对急性胰腺炎患者血清白细胞介素-6及肿瘤坏死因子-α水平的影响[J].临床内科杂志, 2013, 30 (3) :173-175. -
点击查看大图
计量
- 文章访问数: 2086
- HTML全文浏览量: 701
- PDF下载量: 51
- 被引次数: 0
下载:
